PARP inhibition and non-BRCA DNA damage repair mutation study by Dr Rinsinger has been awarded a $50,000 grant by the MIOCA Board of Directors.
They received several worthy proposals and it was a difficult decision, but are thrilled to be able to support Dr. Risinger's important work!